Systematic review of the performance and clinical utility of point of care HIV-1 RNA testing for diagnosis and care

<p><strong>Background</strong></p> Point of-care (POC) HIV-1 RNA tests which are accurate and easy to use with limited infrastructure are needed in resource-limited settings (RLS). We systematically reviewed evidence of POC test performance compared to laboratory-based HIV-1...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Agutu, C, Ngetsa, C, Price, M, Rinke De Wit, T, Omosa-Manyonyi, G, Sanders, E, Graham, S
Định dạng: Journal article
Ngôn ngữ:English
Được phát hành: Public Library of Science 2019
_version_ 1826261418951835648
author Agutu, C
Ngetsa, C
Price, M
Rinke De Wit, T
Omosa-Manyonyi, G
Sanders, E
Graham, S
author_facet Agutu, C
Ngetsa, C
Price, M
Rinke De Wit, T
Omosa-Manyonyi, G
Sanders, E
Graham, S
author_sort Agutu, C
collection OXFORD
description <p><strong>Background</strong></p> Point of-care (POC) HIV-1 RNA tests which are accurate and easy to use with limited infrastructure are needed in resource-limited settings (RLS). We systematically reviewed evidence of POC test performance compared to laboratory-based HIV-1 RNA assays and the potential utility of these tests for diagnosis and care in RLS. <p><strong>Methods</strong></p> Studies published up to July 2018 were identified by a search of PUBMED, EMBASE, Web of Science, CINAHL and Cochrane Central Register of Controlled Trials. Studies evaluating the use of POC HIV-1 RNA testing for early infant diagnosis (EID), acute HIV infection (AHI) diagnosis, or viral load monitoring (VL), compared to centralized testing, were included. Separate search strategies were used for each testing objective. <p><strong>Results</strong></p> 197 abstracts were screened and 34 full-text articles were assessed, of which 32 met inclusion criteria. Thirty studies evaluated performance and diagnostic accuracy of POC tests compared to standard reference tests. Two of the thirty and two additional studies with no comparative testing reported on clinical utility of POC results. Five different POC tests (Cepheid GeneXpert HIV-1 Quantitative and Qualitative assays, Alere q HIV‐1/2 Detect, SAMBA, Liat HIV Quant and Aptima HIV‐1 Quant) were used in 21 studies of VL, 11 of EID and 2 of AHI. POC tests were easy to use, had rapid turnaround times, and comparable accuracy and precision to reference technologies. Sensitivity and specificity were high for EID and AHI but lower for VL. For VL, lower sensitivity was reported for whole blood and dried blood spots compared to plasma samples. Reported error rates for Cepheid GeneXpert Qual (2.0%-5.0%), GeneXpert Quant (2.5%-17.0%) and Alere q HIV‐1/2 Detect (3.1%-11.0%) were higher than in WHO prequalification reports. Most errors resolved with retesting; however, inadequate sample volumes often precluded repeat testing. Only two studies used POC results for clinical management, one for EID and another for VL. POC EID resulted in shorter time-to-result, rapid ART initiation, and better retention in care compared to centralised testing. <p><strong>Conclusions</strong></p> Performance of POC HIV-1 RNA tests is comparable to reference assays, and have potential to improve patient outcomes. Additional studies on implementation in limited-resources settings are needed.
first_indexed 2024-03-06T19:21:08Z
format Journal article
id oxford-uuid:1a20427b-c9bc-4c0c-855d-a24189ca2ea3
institution University of Oxford
language English
last_indexed 2024-03-06T19:21:08Z
publishDate 2019
publisher Public Library of Science
record_format dspace
spelling oxford-uuid:1a20427b-c9bc-4c0c-855d-a24189ca2ea32022-03-26T10:53:03ZSystematic review of the performance and clinical utility of point of care HIV-1 RNA testing for diagnosis and careJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:1a20427b-c9bc-4c0c-855d-a24189ca2ea3EnglishSymplectic Elements at OxfordPublic Library of Science2019Agutu, CNgetsa, CPrice, MRinke De Wit, TOmosa-Manyonyi, GSanders, EGraham, S<p><strong>Background</strong></p> Point of-care (POC) HIV-1 RNA tests which are accurate and easy to use with limited infrastructure are needed in resource-limited settings (RLS). We systematically reviewed evidence of POC test performance compared to laboratory-based HIV-1 RNA assays and the potential utility of these tests for diagnosis and care in RLS. <p><strong>Methods</strong></p> Studies published up to July 2018 were identified by a search of PUBMED, EMBASE, Web of Science, CINAHL and Cochrane Central Register of Controlled Trials. Studies evaluating the use of POC HIV-1 RNA testing for early infant diagnosis (EID), acute HIV infection (AHI) diagnosis, or viral load monitoring (VL), compared to centralized testing, were included. Separate search strategies were used for each testing objective. <p><strong>Results</strong></p> 197 abstracts were screened and 34 full-text articles were assessed, of which 32 met inclusion criteria. Thirty studies evaluated performance and diagnostic accuracy of POC tests compared to standard reference tests. Two of the thirty and two additional studies with no comparative testing reported on clinical utility of POC results. Five different POC tests (Cepheid GeneXpert HIV-1 Quantitative and Qualitative assays, Alere q HIV‐1/2 Detect, SAMBA, Liat HIV Quant and Aptima HIV‐1 Quant) were used in 21 studies of VL, 11 of EID and 2 of AHI. POC tests were easy to use, had rapid turnaround times, and comparable accuracy and precision to reference technologies. Sensitivity and specificity were high for EID and AHI but lower for VL. For VL, lower sensitivity was reported for whole blood and dried blood spots compared to plasma samples. Reported error rates for Cepheid GeneXpert Qual (2.0%-5.0%), GeneXpert Quant (2.5%-17.0%) and Alere q HIV‐1/2 Detect (3.1%-11.0%) were higher than in WHO prequalification reports. Most errors resolved with retesting; however, inadequate sample volumes often precluded repeat testing. Only two studies used POC results for clinical management, one for EID and another for VL. POC EID resulted in shorter time-to-result, rapid ART initiation, and better retention in care compared to centralised testing. <p><strong>Conclusions</strong></p> Performance of POC HIV-1 RNA tests is comparable to reference assays, and have potential to improve patient outcomes. Additional studies on implementation in limited-resources settings are needed.
spellingShingle Agutu, C
Ngetsa, C
Price, M
Rinke De Wit, T
Omosa-Manyonyi, G
Sanders, E
Graham, S
Systematic review of the performance and clinical utility of point of care HIV-1 RNA testing for diagnosis and care
title Systematic review of the performance and clinical utility of point of care HIV-1 RNA testing for diagnosis and care
title_full Systematic review of the performance and clinical utility of point of care HIV-1 RNA testing for diagnosis and care
title_fullStr Systematic review of the performance and clinical utility of point of care HIV-1 RNA testing for diagnosis and care
title_full_unstemmed Systematic review of the performance and clinical utility of point of care HIV-1 RNA testing for diagnosis and care
title_short Systematic review of the performance and clinical utility of point of care HIV-1 RNA testing for diagnosis and care
title_sort systematic review of the performance and clinical utility of point of care hiv 1 rna testing for diagnosis and care
work_keys_str_mv AT agutuc systematicreviewoftheperformanceandclinicalutilityofpointofcarehiv1rnatestingfordiagnosisandcare
AT ngetsac systematicreviewoftheperformanceandclinicalutilityofpointofcarehiv1rnatestingfordiagnosisandcare
AT pricem systematicreviewoftheperformanceandclinicalutilityofpointofcarehiv1rnatestingfordiagnosisandcare
AT rinkedewitt systematicreviewoftheperformanceandclinicalutilityofpointofcarehiv1rnatestingfordiagnosisandcare
AT omosamanyonyig systematicreviewoftheperformanceandclinicalutilityofpointofcarehiv1rnatestingfordiagnosisandcare
AT sanderse systematicreviewoftheperformanceandclinicalutilityofpointofcarehiv1rnatestingfordiagnosisandcare
AT grahams systematicreviewoftheperformanceandclinicalutilityofpointofcarehiv1rnatestingfordiagnosisandcare